It’s been a few weeks since we looked at a teaser from Dr. Stephen Leeb, and I sure do see his name out there a lot, so I thought this one might be interesting for a quick once-over. And incidentally, yes, if you insist on using the Dr., I’ll try to remember to throw it […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
For several years from 12-99 through about 4 years ago, Amylin Pharmaceuticals was 50% of my total portfolio. During my...
Back to the title article, from Forbes we get: Want to Fight a Deadly Fungus? San Diego's Amplyx Just Got $41M For That...